
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US ...
Introduction Hepatocellular carcinoma (HCC) is a primary malignancy of the liver which most commonly occurs in patients with chronic liver disease and cirrhosis.1 Risk factors for HCC include viral hepatitis including hepatitis B virus (HBV) and/or …